Clinical Outcomes Of Bilateral Implantation Of A New Non-Diffractive Extended-Vision Intraocular Lens (Acrysof® Iq Vivity)

To report the clinical (visual and refractive), spectacle independence, patient -reported outcomes following bilateral sequential bilateral implantation of two lenses: a non-diffractive extended-vision intraocular lens (IOLs): AcrySof Vivity DFT015, and a non-diffractive extended-vision intraocular toric lens AcrySof IQ Vivity Toric DFTx15 implanted in cataract surgery. These non-diffractive extended vision IOLs provide a continuous range of focus from distance to near and offers a monofocal quality distance image and visual disturbances profile.

• Department of Ophthalmology, Coimbra Hospital and University Center (CHUC), Coimbra, Portugal
• Clinical Academic Center of Coimbra (CACC), Coimbra, Portugal
• Faculty of Medicine, University of Coimbra (FMUC), Coimbra, Portugal
• Unidade de Oftalmologia de Coimbra (UOC), Coimbra, Portugal

We performed a description of a case series of patients submitted to cataract surgery (phacoemulsification) and bilateral sequential implantation of: a) AcrySof Vivity DFT015 and b) AcrySof IQ Vivity Toric DFTx15, targeting minimonovision.

Clinical post-operative outcome measures, such as UDVA, CDVA, binocular uncorrected intermediate visual acuity – 66 cm (UIVA), binocular uncorrected near visual acuity – 40 cm (UNVA), refraction, spherical equivalent (SE) determined by subjective refraction and residual astigmatism (in group b) were assessed 1-2 months postoperatively in photopic conditions, spectacle independence, photic phenomena and Catquest-9SF questionnaires. A satisfaction and visual disturbances questionnaire was performed.

208 eyes from 104 patients were enrolled, age 64.65±8.84 years old, 67.31% female (70), and submitted to cataract surgery (phacoemulsification) and implantation of Acrysoft Vivity (168 eyes with AcrySof Vivity DFT015 and 40 eyes with AcrySof IQ Vivity Toric DFTx15). Binocular mean UDVA was 0.03 logMAR (± 0.08), binocular mean UIVA was 0.08 logMAR (± 0.07), binocular mean UNVA was 0.14 logMAR (± 0.11) and mean SE was -0.24D (± 0.42D) (min -0.75D, max +0.25D). Mean residual astigmatism in the toric IOL group was 0.3D (± 0.48D). The refractive targets for minimonovision for dominant and nondominant eyes were met in 91.34% and 57.69% of cases, respectively. Outcomes of a satisfaction and visual disturbances questionnaire were excellent.

Our work supports that bilateral implantation of this non-diffractive extended vision IOL in a mini monovison strategy provides excellent uncorrected binocular distance and intermediate visual acuities, and even good near visual acuity in photopic conditions. This IOL provides high level of patient satisfaction even for very demanding patients, spectacle independence and minimizes unwanted visual effects. Excellent performances in satisfaction outcomes and visual disturbances profile were reported.